EyeMacular Regeneration, Inc. — Form D/A
EyeMacular Regeneration, Inc. of St. Paul, MN, a company, filed a Form D amendment with the SEC on 2025-10-09. The offering totals $6.0M, of which $2.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-10-09
- Form: D/A
- Accession: 0002042485-25-000006
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $2.0M
- Remaining: $4.0M
- Minimum investment: $100K
- Investors: 12
- Date of first sale: 2024-10-08
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-527741
Issuer
- Name: EyeMacular Regeneration, Inc.
- CIK: 0002042485
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 1000 Westgate Dr., St. Paul, MN, 55114
- Phone: 404-290-6418
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Gerald R Benjamin | Director | Atlanta, GA |
| David M Brown | Director | Burton, TX |
| Richard L Lindstrom | Director | Nashville, TN |
| Michael Lindsay Olsen | Director | Prairie Village, KS |
| Timothy W Olsen | Director | St. Paul, MN |
| Timothy W Olsen | Executive Officer | St. Paul, MN |
| Virginia W Olsen | Executive Officer | Rochester, MN |
Other filings by this issuer (1)
More